Katie McCarthy is a drug development expert, with over 20 years of experience focusing on Clinical Development and Operations and Program Leadership and Management. She has expertise leading early and late stage cross-functional drug development programs, directing activities and teams for all phases of clinical development, and creating collaborative and productive alliances with partners.
Katie joined Halloran Consulting Group in 2011, and is the Managing Director of their biotechnology and pharmaceutical development business. She often functions as an on-demand Head of Clinical Operations and/or Development, directs clinical development teams, advises on strategic planning initiatives, and provides recommendations related to best practice, efficiency, and process improvement activities. Katie and her team provide on-demand clinical, regulatory, program management, and quality support to companies ranging from small, virtual starts-ups early in development through large pharmaceutical companies with late-stage and commercial assets.
Prior to joining Halloran, Katie held a series of progressive positions with Biogen. She spent five years in Program and Alliance Management, where she drove program strategy and execution for development programs in Neurology. Prior to this, Katie was appointed Chief of Staff to the SVP of Medical Research and successfully designed and led the Medical Research Organizational Effectiveness function. She also spent six years in Clinical Operations as a line manager and Project Manager. Before joining Biogen, Katie was a Clinical Research Coordinator at Massachusetts General Hospital in the Memory and Movement Disorders Unit.
Katie earned a Bachelor of Arts in Psychology from Saint Michael’s College. She is also a Prosci® certified Change Management professional. Katie is a frequent speaker at industry conferences and often focuses on topics related to best practices in clinical development and optimal approaches for small sponsors.